Posted: December 21st, 2017

A client with leukemia is receiving Trimetrexate. After reviewing the client’s chart, the physician orders Wellcovorin (leucovorin calcium). The rationale for administering leucovorin calcium to a client receiving Trimetrexate is to:

. A client with leukemia is receiving Trimetrexate. After reviewing
the client’s chart, the physician orders Wellcovorin (leucovorin calcium).
The rationale for administering leucovorin calcium to a
client receiving Trimetrexate is to:
❍ A. Treat iron-deficiency anemia caused by chemotherapeutic
agents
❍ B. Create a synergistic effect that shortens treatment time
❍ C. Increase the number of circulating neutrophils
❍ D. Reverse drug toxicity and prevent tissue damage